RHOA and cerebral cavernous malformation: KLF4 also drives endothelial‐to‐mesenchymal transition (EndoMT) in CCM models and clinical cavernomas (Maddaluno et al. 2013), a process enhanced by RhoA activity (Piera Velazquez and Jimenez 2019).